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Insulin/IGF-1-like signaling (IIS) is central to growth
and metabolism and has a conserved role in aging.
In C. elegans, reductions in IIS increase stress resis-
tance and longevity, effects that require the IIS-
inhibited FOXO protein DAF-16. The C. elegans tran-
scription factor SKN-1 also defends against oxidative
stressbymobilizing theconservedphase2detoxifica-
tion response. Herewe show that IIS not only opposes
DAF-16 but also directly inhibits SKN-1 in parallel. The
IIS kinases AKT-1, -2, and SGK-1 phosphorylate SKN-
1, and reduced IIS leads to constitutive SKN-1 nuclear
accumulation in the intestine and SKN-1 target gene
activation. SKN-1 contributes to the increased stress
tolerance and longevity resulting from reduced IIS
and delays aging when expressed transgenically.
Furthermore, SKN-1 that is constitutively active in-
creases life span independently of DAF-16. Our find-
ings indicate that the transcription network regulated
by SKN-1 promotes longevity and is an important
direct target of IIS.
INTRODUCTION
In many studies of aging, extended longevity correlates with en-
hanced resistance against oxidative damage and other stresses
(Finkel and Holbrook, 2000; Lithgow and Walker, 2002). In C.
elegans, both life-span and stress resistance can be increased
by the alteration of several processes, including insulin/IGF-1-
like signaling (IIS) (Friedman and Johnson, 1988; Gottlieb and
Ruvkun, 1994; Kenyon et al., 1993; Larsen, 1993), caloric intake
(Houthoofd et al., 2002), mitochondrial respiration (Dillin et al.,
2002; Lakowski and Hekimi, 1996; Lee et al., 2003), and germline
function (Arantes-Oliveira et al., 2002). It is a formidable but crit-ical challenge to understand how modulation of these processes
might inhibit or defend against stresses that contribute to aging.
Reductions in IIS have been associated with increased stress
resistance and longevity in diverse species (Kenyon, 2005).
Studies in worms and flies have established the paradigm that
these effects derive from increased activity of the FOXO tran-
scription factors, which are inhibited through IIS-induced phos-
phorylation (Figure 1A) (Antebi, 2007; Kenyon, 2005). FOXO pro-
teins are also important in many of the biological effects of insulin
in mammals (Accili and Arden, 2004; van der Horst and Burger-
ing, 2007). In C. elegans, signaling through the IIS receptor DAF-
2 ultimately directs the related kinases AKT-1, -2, and SGK-1 to
phosphorylate the FOXO protein DAF-16, thereby inhibiting its
accumulation in nuclei (Henderson and Johnson, 2001; Hert-
weck et al., 2004; Lin et al., 2001; Ogg et al., 1997). DAF-16 is
required for phenotypes that are associated with decreased
IIS, including increases in stress resistance, longevity, and
the propensity to undergo diapause, the formation of long-lived
dauer larvae that can survive adverse environmental conditions
(Kenyon, 2005; Kenyon et al., 1993; Kimura et al., 1997). DAF-
16 regulates genes that represent diverse processes, including
resistance to oxidative and other stresses (Antebi, 2007; Kenyon,
2005).
The phase 2 detoxification response also provides a conserved
defense against oxidative stress and consists of numerous en-
zymes that scavenge free radicals and other reactive compounds
and produce or transfer glutathione (McMahon et al., 2001). In C.
elegans the phase 2 response is orchestrated by the transcription
factor SKN-1. SKN-1 initiates development of the feeding and
digestive system during the earliest embryonic stages, then is re-
quired postembryonically for normal life span and stress resis-
tance (An and Blackwell, 2003; Bowerman et al., 1992). SKN-1
is present in nuclei constitutively in the ASI neurons (putative hy-
pothalamus) (An and Blackwell, 2003), where it is required for lon-
gevity to be extended by dietary restriction (DR), a condition that
increases longevity in organisms as diverse as yeast and rodents
(Bishop and Guarente, 2007). The stress resistance function ofCell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc. 1025
Figure 1. Accumulation of SKN-1 in Intestinal Nuclei Is Inhibited by DAF-2
(A) A partial schematic of C. elegans insulin-like signaling and our working model.
(B) skn-1 isoforms, alleles, and transgenes. The SKN-1A isoform is transcribed from an upstream operon promoter and differs from SKN-1C by the addition of
90 amino acids at its N terminus. SKN-1B and SKN-1C are each expressed from their own distinct upstream promoters (An and Blackwell, 2003; Bishop and
Guarente, 2007). The skn-1(zu67), (zu129), and (zu135) mutations each create a premature stop codon (B. Bowerman, personal communication). Green fluores-
cent protein (GFP) is fused to the C terminus of SKN-1 in the transgenes indicated at the bottom. Strains that carry these and other transgenes are described in
Table S2. The skn-1a/c RNAi construct includes only coding sequence and targets both SKN-1A and SKN-1C but does not alter the levels of SKN-1B in the ASI
neurons (Bishop and Guarente, 2007).
(C) SKN-1::GFP accumulates in intestinal nuclei when DAF-2 activity is reduced.
(D) Intestinal expression of SKN-1B/C::GFP in daf-2(e1370) derives from SKN-1C.
(E) Quantification of SKN-1 intestinal nuclear accumulation. Here and in Figure 2, results of experiments performed on L4 larvae have been combined and scored
as described in the Supplemental Experimental Procedures and in An and Blackwell (2003) and An et al. (2005). p values were derived from a chi2 test.SKN-1 is mediated by its expression in the intestine (digestive
system) (Bishop and Guarente, 2007), where SKN-1 accumulates
in nuclei and activates phase 2 gene expression inducibly in re-
sponse to stress (An and Blackwell, 2003). In the intestine, phos-
phorylation of SKN-1 by p38/mitogen-activated protein kinase
(MAPK) signaling is required for its accumulation in nuclei, while
negative regulation via glycogen synthase kinase-3 (GSK-3)
phosphorylation is needed to prevent this from occurring consti-
tutively (Figure 1A) (An et al., 2005; Inoue et al., 2005).
As daf-16 is required for the increased stress resistance and
longevity that are seen when IIS is reduced, it has seemed likely
that these effects of decreased IIS could be accounted for by1026 Cell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc.increased DAF-16 activity. However, we reasoned that if it is ad-
vantageous for IIS to inhibit stress response genes by acting on
DAF-16, then IIS might also oppose SKN-1 (Figure 1A). Accord-
ingly, here we show that reductions in IIS cause SKN-1 to accu-
mulate constitutively in intestinal nuclei in the absence of stress
and to activate phase 2 target genes. Importantly, these events
do not require daf-16. AKT-1, -2, and SGK-1 phosphorylate
SKN-1 at multiple sites, and mutation of an AKT phosphorylation
site results in SKN-1 being present in intestinal nuclei constitu-
tively. skn-1mutations significantly suppress the oxidative stress
resistance and longevity phenotypes associated with reduced
IIS. Aging is delayed when SKN-1 is expressed transgenically,
and a mutant SKN-1 form that localizes constitutively to intesti-
nal nuclei increases life span in the absence of daf-16. In sum-
mary, our data indicate that IIS directly inhibits SKN-1 in parallel
to DAF-16, that SKN-1 contributes to the stress and longevity
phenotypes associated with reduced IIS, and that SKN-1 defines
an important pro-longevity mechanism.
RESULTS
DAF-2 Signaling Inhibits SKN-1 Accumulation
in Intestinal Nuclei
If IIS inhibits SKN-1 analogously to DAF-16 (Figure 1A), then re-
duced DAF-2 signaling should allow SKN-1 to accumulate in
intestinal nuclei. To test this idea, we first investigated how reduc-
tions in DAF-2 activity affect the distribution of SKN-1 that is ex-
pressed from the previously described SKN-1B/C::GFP trans-
gene (Figure 1B). This transgene rescues the maternal lethality,
stress sensitivity, and DR-associated longevity defects of skn-1
mutants (An and Blackwell, 2003; An et al., 2005; Bishop and
Guarente, 2007). SKN-1B/C::GFP encodes two of three SKN-1
isoforms, SKN-1C and SKN-1B, which are expressed in the
intestine and ASI neurons, respectively (Bishop and Guarente,
2007). In wild-type (WT) animals that carry extrachromosomal
or integrated SKN-1B/C::GFP, SKN-1::GFP is generally unde-
tectable in intestinal nuclei except under stress conditions or af-
ter inhibition of its phosphorylation by GSK-3 (An and Blackwell,
2003; An et al., 2005). In contrast, SKN-1::GFP was constitutively
present in intestinal nuclei of transgenic daf-2(e1370) and daf-
2(e1368) animals or in WT transgenics exposed to daf-2 RNA
interference (RNAi) at either 20C or low temperature (16C) (Fig-
ures 1C and 1E; see also Figures S1A–S1C available online). This
nuclear SKN-1 appeared to correspond to SKN-1C because
RNAi against this isoform prevented SKN-1::GFP from ac-
cumulating in intestinal nuclei in response to daf-2 mutation
(Figure 1D).
We also analyzed a transgene that encodes all three SKN-1
isoforms in the context of a large operon (SKN-1op::GFP; Fig-
ure 1B). In the WT background this transgene was expressed
in a similar pattern to SKN-1B/C::GFP (not shown), and in daf-
2(e1370) SKN-1 that was expressed from SKN-1op::GFP also
accumulated in intestinal nuclei constitutively (Figure 1E). In
contrast to these effects in the intestine, daf-2 mutation did not
obviously alter the levels of nuclear SKN-1::GFP in the ASI neu-
rons (Figures 1C and 1D; data not shown). We conclude that sig-
naling through DAF-2 may be required to prevent SKN-1 from
accumulating constitutively in intestinal nuclei.
DAF-2 Signaling Inhibits SKN-1 Directly,
through Phosphorylation
Signaling through DAF-2 ultimately activates the AKT-1, -2, and
SGK-1 kinases, which phosphorylate and inhibit DAF-16 (Fig-
ure 1A) (Cahill et al., 2001; Hertweck et al., 2004; Lin et al.,
2001). RNAi knockdown of akt-1;akt-2 or sgk-1 dramatically in-
creased the presence in intestinal nuclei of SKN-1::GFP that
was expressed from either SKN-1B/C::GFP or SKN-1op::GFP
(Figures 2A and 2B), supporting the model that IIS inhibits
SKN-1 directly. Importantly, daf-16 was not required for SKN-1
expression, or for the nuclear accumulation of SKN-1 that re-sulted from reductions in IIS. A constitutively nuclear SKN-1 sub-
stitution mutant in which a critical inhibitory GSK-3 phosphoryla-
tion site has been altered (SKN-1(S393A); An et al., 2005) was
appropriately present in intestinal nuclei in null daf-16 animals
(Figure S2). In addition, in a null daf-16 background, RNAi of
the IIS kinases still increased the levels of intestinal nuclear
SKN-1::GFP expressed from SKN-1op::GFP (Figure 2A). Finally,
in daf-2(e1370) animals, the nuclear accumulation of SKN-1 ex-
pressed from SKN-1B/C::GFP was not reduced by daf-16 RNAi
(Figure S1D). We conclude that the IIS pathway inhibits SKN-1
in the intestine, and that this regulation occurs independently
of DAF-16.
We previously observed that p38 MAPK signaling is required
for SKN-1 to accumulate in intestinal nuclei not only in response
to stress but also when GSK-3 phosphorylation of SKN-1 is
inhibited under normal conditions (An et al., 2005; Inoue et al.,
2005). In the latter case, even though negative regulation of
SKN-1 is impaired, the low-level background p38 signaling that
is seen under normal conditions is still required. To test whether
p38 signaling is also needed for SKN-1 to be present in intestinal
nuclei when IIS is reduced, we performed akt-1;akt-2 and sgk-1
RNAi in animals that lacked the p38 pathway MAPK kinase SEK-
1 (Inoue et al., 2005). In sek-1(km4) mutants, SKN-1::GFP failed
to accumulate in intestinal nuclei in response to IIS kinase
RNAi (Figure 2B). Similarly, RNAi of the IIS kinases did not allow
nuclear accumulation of a SKN-1 mutant in which two key p38
phosphorylation sites had been altered (Figure S3). We conclude
that the SKN-1 nuclear accumulation that is allowed when IIS is
reduced is appropriately dependent upon p38 MAPK signaling.
We next investigated whether SKN-1 is phosphorylated by the
downstream IIS kinases AKT-1, -2, and SGK-1. Analysis using
SCANSITE identified seven potential AKT phosphorylation
motifs within SKN-1C (Table S1). Four additional potential AKT
phosphorylation motifs were detected within the unique N-termi-
nal 90 amino acids of SKN-1A (SKN-1A(1–90); Table S1), which is
predicted by expressed sequence tag analysis to be the most
abundant SKN-1 isoform (http://www.wormbase.org). AKT-
1::GFP, AKT-2::GFP, and SGK-1::GFP that were purified from
WT C. elegans (Hertweck et al., 2004) each phosphorylated
full-length SKN-1C in vitro at least as robustly as they phosphor-
ylated DAF-16 (Figure 2C). In contrast, SKN-1A(1–90) was phos-
phorylated by AKT-1 and AKT-2 but not SGK-1 (Figure 2D), con-
sistent with the previous finding that AKT-1, -2, and SGK-1 differ
with respect to their phosphorylation sites within the mammalian
DAF-16 homolog FOXO3a (Brunet et al., 2001). Significantly,
SKN-1 was not phosphorylated robustly by these same kinases
if they were purified from daf-2(e1370) animals (Figures 2C and
2D). We conclude that SKN-1 is a direct substrate of the down-
stream IIS kinases, and that their phosphorylation of SKN-1
depends upon signaling through DAF-2.
We then performed a partial mapping of IIS kinase phosphor-
ylation sites in SKN-1. Within SKN-1A(1–90), Ala substitution at
the strongly predicted AKT site Ser12 reduced its phosphoryla-
tion by AKT-2 dramatically, (Figure 2D) identifying Ser12 as an
AKT-2 site. AKT-1 phosphorylation was only slightly reduced
by this mutation but was substantially decreased by concurrent
substitution of Ser12 and each of three other sites within this re-
gion (Figure 2E). AKT and SGK also preferentially phosphorylatedCell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc. 1027
Figure 2. DAF-2 Signaling Inhibits Nuclear Accumulation of SKN-1 Directly, and Independently of DAF-16
(A) akt-1;akt-2 or sgk-1 RNAi allows daf-16-independent accumulation of SKN-1 in intestinal nuclei. Expression of SKN-1op::GFP was monitored. akt-1 or akt-2
RNAi had a similar effect to combined akt-1;akt-2 RNAi (data not shown).
(B) RNAi depletion of the downstream IIS kinases causes sek-1-dependent accumulation of SKN-1 in intestinal nuclei. Expression of SKN-1B/C::GFP was
monitored.
(C) SKN-1C is phosphorylated by AKT-1, -2, and SGK-1 comparably to DAF-16, dependent upon daf-2. Here and in (D)–(G), AKT-1::GFP, AKT-2::GFP, and SGK-
1::GFP were immunoprecipitated from WT or daf-2(e1370) C. elegans lysates with anti-GFP antibody, quantitated by western blotting with anti-GFP, and used to
phosphorylate purified GST-fused SKN-1 or DAF-16 proteins with [gP32]ATP. GST controls are shown in Figure S4B. These kinases appropriately required
activation in C. elegans, as they did not phosphorylate SKN-1 after they had been expressed in E. coli (Figure S4A).
(D) The unique 90 aa region at the SKN-A N terminus (SKN-1A(1–90)) is phosphorylated by the AKT kinases but not SGK-1, dependent upon daf-2.
(E) Partial mapping of AKT-1 sites within SKN-1A(1–90).
(F) AKT and SGK phosphorylate particular regions of SKN-1C. Here and in (G), residues are numbered as in SKN-1A, so that the first residue of SKN-1C is
numbered as 91.
(G) Partial mapping of AKT-1, -2, and SGK-1 sites within SKN-1C fragments.
(H and I) Substitution of a strongly predicted AKT site within SKN-1A(1–90), Ser12 (Table S1), results in nuclear accumulation of SKN-1A::GFP. In some lines low
levels of SKN-1::GFP were observed in additional head neurons, hypodermis, and other tissues, particularly if Ser12 was mutated (data not shown).
p values were derived from a chi2 test.1028 Cell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc.
different regions or individual sites within the remainder of SKN-
1, which corresponds to the SKN-1C isoform (Figures 2F and 2G;
Table S1). Together, our data show that AKT-1, -2, and SGK-1
phosphorylate SKN-1 at multiple overlapping and distinct sites.
To investigate whether SKN-1 is regulated directly by IIS ki-
nase phosphorylation in vivo, we substituted Ala at its most
strongly predicted AKT site (Ser12 of SKN-1A) (Table S1), within
the SKN-1op::GFP transgene. In each transgenic line examined,
this substitution resulted in dramatic constitutive intestinal nu-
clear accumulation of SKN-1A (Figures 2H and 2I). This finding
shows that SKN-1A is expressed in the intestine, and that the
AKT phosphorylation site Ser12 is essential for its appropriate
regulation. This strongly supports the model that signaling
through the DAF-2 pathway directly inhibits SKN-1 in vivo.
Inhibition of SKN-1 Target Genes by IIS
Given that IIS directly inhibits the SKN-1 protein in the intestine, it
follows that IIS should also reduce expression of SKN-1 target
genes. To test this idea, we first asked how reductions in IIS af-
fect expression of two SKN-1 target reporter transgenes (Figures
3A and 3B). In the intestine, SKN-1 directly induces expression
of gcs-1 (g-glutamyl cysteine synthetase), which encodes an
enzyme rate-limiting for glutathione biosynthesis (Figure 3A)
(An and Blackwell, 2003). In the intestine a gcs-1::GFP transcrip-
tional reporter is generally expressed at very low levels in the ab-
sence of stress but was upregulated by akt-1;akt-2 or sgk-1RNAi
(Figure 3C). This induction was abolished by mutation of an
important SKN-1 binding site (gcs-1D2mut3; Figure 3A) but not
by absence of daf-16 (Figure 3C), indicating that SKN-1 but
not DAF-16 was required for IIS kinase RNAi to activate the
gcs-1 promoter. Interestingly, gcs-1 was not induced by daf-2
RNAi, implying that its regulation by AKT and SGK-1 might in-
volve an additional input (data not shown). In contrast, a transla-
tional fusion reporter for the SKN-1 target gene gst-7 (glutathione
S-transferase; Figure S5) was comparably induced in the intes-
tine by either daf-2 or IIS kinase RNAi (Figures 3B and 3D).
Wenextusedquantitative (Q)-PCRtoanalyzehowdaf-2mutation
affected the levels of mRNA expressed from a set of known or pre-
dicted SKN-1 target phase 2 genes (An and Blackwell, 2003; Kell
et al., 2007). As would be expected, SKN-1 was not required for
daf-2mutation to induce expression of a negative control for our ex-
periments, the DAF-16 target sod-3 (Figure 3E) (Antebi, 2007). The
levels of gcs-1 mRNA were largely unaffected in this daf-2 mutant
(Figure 3F), in agreement with our reporter data and the high levels
of skn-1-independentgcs-1expression seen in the pharynx (An and
Blackwell, 2003). In contrast, four different gst genes were strongly
upregulated bydaf-2mutation in a manner that was substantially or
completely dependent upon skn-1. (Figures 3G–3J). DAF-16 con-
tributed to induction of some of these genes, but the SKN-1 target
gst-10 was upregulated by daf-2 mutation independently of daf-16
(Figures 3G–3J). Together, our results indicate that when DAF-2
pathway signaling is reduced, SKN-1 induces a gene expression
program that overlaps only partially with that of DAF-16.
skn-1 Contributes to the Increased Longevity
and Stress Resistance Associated with Reduced IIS
Having established that DAF-2 and IIS inhibit SKN-1 directly, and
thereby suppress SKN-1-dependent gene expression, we nextasked whether SKN-1 contributes to phenotypes that are asso-
ciated with decreased IIS. We engineered daf-2;skn-1 double
mutants that each carried one of three skn-1 mutations, along
with one of two daf-2 alleles. Each skn-1 mutation (Figure 1B)
results in reduced stress resistance and longevity (Figure 4; Ta-
ble 1) (An and Blackwell, 2003), failure of DR to extend life span
(Bishop and Guarente, 2007), and maternally derived embryonic
lethality (Bowerman et al., 1992). The class 2 daf-2 mutant e1370
is stress resistant and lives much longer than WT at 20C (Fig-
ures 4A and 4C), but this increased life span is accompanied
by various dauer-like abnormalities (Gems et al., 1998; Kimura
et al., 1997). The class 1 daf-2 mutation e1368 increases life
span to a lesser extent (Figure 4D), but these animals appear es-
sentially normal. We also tested how skn-1 mutations affect sim-
ilar phenotypes caused by RNAi of the IIS downstream kinases.
At 25C, sgk-1 RNAi increases both oxidative stress resistance
and life span, dependent upon daf-16 (Hertweck et al., 2004).
Previously, life span was not extended when akt-1RNAi was per-
formed in the akt-2(ok393) mutant (Hertweck et al., 2004), but we
have now observed that akt-1;akt-2 RNAi significantly increases
stress resistance and life span in an RNAi hypersensitive strain
(Figures 4B and 4F; Table 1). This suggests that AKT-1, -2, and
SGK-1 may contribute comparably to the effects of DAF-2
signaling on stress resistance and longevity.
Initially, we tested whether the IIS-associated phenotypes of
dauer formation and elevated stress resistance require skn-1.
skn-1 RNAi did not prevent the constitutive dauer entry associ-
ated with the daf-2(e1370) mutation, or akt-1;akt-2 RNAi (Sup-
plemental Data). In contrast, and consistent with its role in phase
2 detoxification, mutations in skn-1 dramatically suppressed the
increases in oxidative stress resistance seen in each of these
contexts of reduced IIS, and also with sgk-1 RNAi (Figures 4A
and 4B).
Wethen investigatedhowskn-1contributes to the increased lon-
gevity deriving from decreased daf-2 function. Only skn-1(zu129)
suppressed the increased longevity of the class 2 daf-2 allele
e1370 (Figure 4C; Table 1). In contrast, all three skn-1 mutations
significantly reduced the life span of the class 1 daf-2 mutant
e1368 (Figure 4D; Table 1). These skn-1 mutations also altered
the shapeof thedaf-2(e1368)survivalplot, so that the longest-living
double mutant animals appeared to be less dependent upon skn-1
than the remaining population (Figure 4D). Accordingly, when we
excluded the 20%most long-livedanimals fromstatisticalanalysis,
two of three skn-1 mutations affected death rate more severely in
daf-2(e1368) animals than in WT (Figure S7; Tables S3 and S4).
Importantly, an RNAi-sensitive genetic background skn-1 RNAi
decreased the life span of daf-2(e1368) but not control animals
(Figure 4E; Tables 1 and S4), indicating that this daf-2 mutant is
more susceptible than WT to a reduction in SKN-1 levels. daf-
2(e1368) life span was similarly decreased by either skn-1 or skn-
1a/c RNAi (Figure 4E; Tables 1 and S4), indicating that the SKN-1
A and/or C isoforms are required for the longevity associated
with daf-2(e1368). daf-2(e1368) life span was also decreased by
feeding of skn-1RNAi from the beginning of adulthood (Figure S8),
indicating an effect on aging, not development.
Mutations in skn-1 also suppressed the life-span extensions
associated with reductions in IIS kinase levels. Each of two skn-1
alleles that we analyzed (zu67 and zu129) completely eliminatedCell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc. 1029
Figure 3. SKN-1 Target Genes downstream of IIS
(A and B) Schematics of the gcs-1 promoter (An and Blackwell, 2003) and theGST-7::GFP translational fusion. Triangles mark SKN-1 binding sites. gcs-1D2::GFP
lacks a promoter region required for SKN-1-independent pharyngeal expression, and gcs-1D2mut3::GFP lacks a SKN-1 binding site that is important for skn-1-
dependent gcs-1 expression in the intestine and ASI neurons (An and Blackwell, 2003).1030 Cell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc.
the dramatic increase in life span deriving from sgk-1 RNAi
(Figure 4G; Tables 1 and S4). In addition, two of three skn-1 alleles
significantly reduced the life spans of akt-1;akt-2 RNAi animals
(Figure 4F; Table 1). We conclude that SKN-1 makes important
contributions to the increases in stress resistance and longevity
that are associated with reductions in IIS activity.
Next, we investigated whether skn-1 affects the long life spans
of animals with reduced mitochondrial electron transport chain
activity to find out whether skn-1 mutations might cause a gen-
eral sickness that limits life span (Dillin et al., 2002; Lee et al.,
2003; Rea et al., 2007). In agreement with a recent report (Rea
et al., 2007), a skn-1 mutation did not reduce the large increases
in life span associated with RNAi against either cytochrome c re-
ductase (cyc-1) or cytochrome c oxidase (cco-1) (Figures 4H and
S9; Table 1). This indicates that while skn-1 is important for life
span in long-lived animals in which IIS is reduced, lack of
skn-1 does not limit longevity nonspecifically.
SKN-1 Promotes Longevity
The involvement of skn-1 in the longevity effects of IIS led us to
investigate whether SKN-1 has an independent pro-longevity
function. Previously, life span was modestly increased by trans-
genic overexpression of either WT or constitutively nuclear forms
of DAF-16 (Henderson and Johnson, 2001; Lin et al., 2001). To
investigate whether modulation of SKN-1 expression can extend
life span, we first analyzed otherwise WT strains in which either
the SKN-1B/C::GFP or SKN-1B/C S393A::GFP transgenes
were present. The SKN-1B/C S393A::GFP transgene, which ex-
presses constitutively nuclear SKN-1 in the intestine, increased
mean life span variably but consistently (by 5%–21%; Figure 5A;
Table 2). A modest increase was also seen with SKN-1B/C::GFP
(Ex001; Figure 5B; Table 2).
We had previously observed that skn-1 transgenesnot only res-
cue the oxidative stress sensitivity of skn-1(zu67)mutants but also
increase their stress resistance to well beyond that of WT (An
et al., 2005). Similarly, strains in which skn-1(zu67) was rescued
with these transgenes also lived longer than wild-type animals
that carried the same transgene arrays (arrays Ex001 and
Ex008, Figures 5A and 5B; Table 2). This difference was corrobo-
rated in independent strains that were generated by breeding the
Ex001[SKN-1B/C::GFP] array from the WT into skn-1(zu67) and
skn-1(zu129) (Figures S10A, S10B, and S11), and in an additional
skn-1(zu67) strain carrying SKN-1B/C S393A::GFP (Ex020, Fig-
ure 5B; Table 2). Perhaps an optimal window of SKN-1 expression
is important for longevity because we found that expression of
SKN-1 from high-copy arrays can be toxic (data not shown). Sig-
nificantly, rescued skn-1(zu67) Ex001[SKN-1B/C::GFP] animals
maintained the ability to move longer than WT (Figure S10C), indi-
cating that transgenic skn-1 expression delayed the aging pro-cess. RNAi that was targeted to transgenic SKN-1C (skn-1a/c
RNAi, Figure 1B) eliminated expression of intestinal nuclear
SKN-1 fromSKN-1B/CS393A::GFP (Figure S12) and suppressed
the extended life span of a transgenically rescued skn-1(zu67)
strain (Figure 5C). Taken together, our results indicate that
SKN-1 promotes longevity, an effect that appears to require the
SKN-1C isoform.
We next investigated whether daf-16 is required for transgenic
SKN-1 to increase life span because of the general importance of
daf-16 for C. elegans longevity and because SKN-1 and DAF-16
overlap in regulating some target genes (Figures 3E–3J). When
we bred a SKN-1 S393A transgenic array (Ex008) into the null
mutant daf-16(mgDf47), life span was modestly but significantly
increased in two of three experiments (Figure 5D; Tables 2 and
S6). Similarly, after daf-16 RNAi the life spans of skn-1(zu67)
animals were reduced, but presence of an array that expresses
constitutively nuclear SKN-1(S393A) (Ex008 or 020) still in-
creased skn-1(zu67) life span to beyond that of WT (Figure 5E;
Table 2). Interestingly, daf-16 RNAi completely suppressed the
life-span extension associated with transgenic WT SKN-1 (Fig-
ure S13; Table 2), suggesting that reductions in DAF-16 levels
not only reduce life span but also might free up negative regula-
tory mechanisms that act on SKN-1. Taken together, our data
suggest that SKN-1 can promote longevity independently
of DAF-16, provided that SKN-1 is released from negative
regulation in the intestine.
DISCUSSION
It is well established that FOXO proteins are inhibited directly by
the IIS pathway, and that the FOXO protein DAF-16 is required
for the increased longevity and stress resistance that result
from decreased IIS in C. elegans (Kenyon, 2005). This has
made it difficult to imagine that another transcription factor might
be regulated similarly by IIS in parallel to FOXO and could play a
major role in IIS-regulated processes. However, here we have
identified SKN-1 as the second transcription factor that is known
to be inhibited directly by IIS. We have also shown that IIS inhibits
SKN-1 target genes and that SKN-1 contributes to the stress re-
sistance and longevity phenotypes of reduced IIS and functions
as a pro-longevity factor.
Direct Regulation of SKN-1 by IIS
Multiple lines of evidence indicate that IIS inhibits SKN-1 in the
intestine directly (Figure 1A). Reductions in IIS activity resulted
in SKN-1A and SKN-1C being present in intestinal nuclei in the
absence of either stress or DAF-16 and in induction of SKN-1
target genes (Figures 1E, 2A, 2B, and 3). SKN-1 isoforms were
phosphorylated by AKT-1, -2, and SGK-1 at multiple sites, and(C) gcs-1::GFP is induced in the intestine independently of daf-16 in response to akt-1;akt-2 and sgk-1 RNAi. Here and in (D), results of multiple experiments
performed on L4 larvae have been combined and scored as described in the Supplemental Experimental Procedures and An and Blackwell (2003) and An
et al. (2005). p values were derived from a chi2 test. akt-1 and akt-2 RNAi were also performed separately and shown to have a similar effect to combined
akt-1;akt-2 RNAi (data not shown).
(D) GST-7::GFP is induced in response to daf-2, akt-1;akt-2, or sgk-1 RNAi.
(E–J) SKN-1- and DAF-16-responsive genes that are upregulated in daf-2(e1370) L4 larvae were identified by quantitative PCR, using actin (act-1) as a control.
The level of skn-1 mRNA in these samples was also measured (Figure S6). One representative experiment is shown, error bars represent the SEM, and p values
were derived from a Student’s t test.Cell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc. 1031
Figure 4. skn-1 Mutations Suppress the Longevity and Stress Resistance Phenotypes Conferred by Reduced IIS
(A) skn-1 contributes to the oxidative stress resistance phenotype of daf-2(e1370) mutants. A representative experiment is shown in which animals were exposed
to 7.5 mM t-butyl hydrogen peroxide. Here and in (B), error bars represent the SEM.
(B) skn-1 contributes to the stress resistance phenotypes conferred by sgk-1 or akt-1;akt-2RNAi. Animals were scored after 5 days exposure to 150 mM paraquat.
Data were combined from at least three experiments with n > 90 for each group.
(C) Life-span analysis of daf-2(e1370); skn-1 mutants.1032 Cell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc.
mutation of an AKT site (Ser12) led to SKN-1A being present in
intestinal nuclei constitutively (Figures 2H and 2I). The AKT and
SGK kinases differed in their preferences for sites within SKN-1,
consistent with previous analyses of their phosphorylation of
FOXO (Brunet et al., 2001). The complexity of this regulation
could potentially allow SKN-1 to integrate inputs from multiple
signals or molecular interactions.
We also observed that SKN-1 contributes significantly to some
IIS-associated phenotypes. skn-1 mutations dramatically sup-
pressed the increases in stress resistance deriving from sgk-1
RNAi, akt-1;akt-2 RNAi, and the daf-2(e1370) mutation (Figures
4A and 4B). Lack of skn-1 completely suppressed the increased
life span deriving from sgk-1 RNAi, reduced the extended lon-
gevity of akt-1;akt-2 RNAi animals (Figures 4F and 4G), and sup-
pressed the increased life span of the class 1 daf-2 allele e1368
(Figure 4D). Importantly, skn-1 RNAi reduced the life span of
daf-2(e1368) but not WT animals (Figure 4E), indicating that
daf-2(e1368) was more severely affected than WT by partial
loss of skn-1 function. In contrast, skn-1 mutation did not sup-
press the long life associated with RNAi of mitochondrial respira-
tory chain components (Figures 4H and S9), indicating that lack
of skn-1 does not reduce life span nonspecifically. skn-1 muta-
tions also did not consistently suppress the life-span extension
of daf-2(e1370) mutants (Figure 4C). However, dauer-like pheno-
types are associated with this class 2 allele (Gems et al., 1998),
suggesting that this difference might reflect the apparent
dispensability of SKN-1 for dauer formation (Supplemental Data).
The simplest model to explain the contributions of SKN-1 to
IIS-associated longevity is that they derive from phase 2 detoxifi-
cation gene expression in the intestine. Our finding that skn-1a/c
RNAi suppresses daf-2(e1368) longevity (Figure 4E) is consistent
with this idea, although we cannot exclude that other tissues or
SKN-1 functions are involved. We conclude that daf-16 is neces-
sary but not sufficient to confer the increases in stress resistance
and longevity that are associated with reduced IIS, and that
these increases also involve skn-1.
In contrast to the regulation of SKN-1 by IIS in the intestine,
daf-2 mutation did not obviously affect SKN-1 levels in the ASI
neurons (Figure 1C; not shown), in which SKN-1B is required
for DR to extend life span (Bishop and Guarente, 2007). How-
ever, we cannot exclude that IIS might subtly influence the levels
or activity of endogenous SKN-1 in ASI. This possibility could
help resolve the apparent paradox that in C. elegans most DR
protocols extend life span independently of daf-16, and there-
fore seemingly without input from IIS (Antebi, 2007; Bishop and
Guarente, 2007; Greer et al., 2007; Houthoofd et al., 2003;
Kenyon, 2005; Panowski et al., 2007).
SKN-1 is the sequence and functional counterpart to
the mammalian NF-E2-related factor (Nrf) proteins (An andBlackwell, 2003), which orchestrate the phase 2 detoxification
response (Hayes and McMahon, 2001). Our results predict that
the conserved IIS pathway might also regulate mammalian Nrf
proteins, which include potential AKT sites (Table S1). Why
would it be advantageous for IIS to decrease stress resistance?
Many signaling cascades are influenced by redox status (Tonks,
2005). In particular, IIS is attenuated by protein tyrosine phos-
phatase (PTP)1B, which is inhibited by reactive oxygen species
(ROS) via the oxidation of conserved cysteine residues (Gold-
stein et al., 2005; Tonks, 2005). Thus, by inhibiting DAF-16/
FOXO and SKN-1/Nrf, IIS could suppress antioxidant defenses
that would lead to a reducing environment, and that in turn might
decrease IIS effectiveness. This is consistent with evidence that
insulin induces starved cells to produce a ‘‘burst’’ of ROS, and
that IIS functions more effectively under oxidative conditions
(Goldstein et al., 2005).
Pro-longevity Functions of SKN-1
Our finding that transgenic SKN-1 expression extends life span
(Figures 5A and 5B) demonstrates that skn-1 has an independent
pro-longevity function. This activity appears to require the action
of the intestinal SKN-1C isoform because it is suppressed by
skn-1a/c RNAi (Figure 5C). This pro-longevity activity of SKN-1
thus appears to be distinct from its ASI-mediated role in DR-
induced longevity (Bishop and Guarente, 2007). The observation
that transgenic SKN-1 increased life span more robustly in skn-1
mutants than in the WT (Figures 5A and 5B) suggests that the
systemic effects of SKN-1 expression may be complex. How-
ever, taken together, our data demonstrate that SKN-1 levels
can be adjusted to extend life span and delay aging. We propose
that the ancestral function of SKN-1 in phase 2 detoxification can
be modulated by either reductions in IIS or adjustment of SKN-1
expression to extend life span, raising the exciting possibility that
this detoxification system might be of general and conserved im-
portance for longevity.
In the context of reduced IIS, SKN-1 and DAF-16 appeared to
have both distinct and overlapping functions (Figure 3). daf-16
contributed to expression of some skn-1-dependent phase 2 de-
toxification genes (Figures 3E–3I), but other SKN-1 targets were
daf-16 independent (Figure 3J), consistent with our finding that
transgenic expression of SKN-1 S393A increased longevity inde-
pendently of daf-16 (Figures 5D and 5E). Our data indicate that
SKN-1 has important activities that are largely independent of
DAF-16, making it of intense interest to dissect the extent to which
these two transcription factors cooperate or act independently
under normal, stress, and reduced IIS conditions. It is interesting
that transgenic overexpression of neither DAF-16 or SKN-1 reca-
pitulates the dramatic increases in longevity seen with reductions
in DAF-2 function (Lin et al., 2001; Figure 5). One possibility is that(D) skn-1 suppresses the longevity of daf-2(e1368) mutants.
(E) In the RNAi-sensitive rrf-3 background (Simmer et al., 2002), the life-span increase seen in daf-2(e1368) is comparably suppressed by either skn-1 or skn-1a/c
RNAi. RNAi bacteria were provided from the L1 stage.
(F and G) skn-1 mutations suppress the life-span extension conferred by akt-1;akt-2 or sgk-1 RNAi. Survival assays were carried out at 25C, are from adulthood,
and represent the combined data from at least two experiments.
(H) skn-1 mutation does not suppress the life-span extension conferred by cyc-1 RNAi. The life-span experiments in (C) and (D) were carried out on OP50, but all
others were performed on HT115 lawns. Life-span data in this Figure are summarized in Table 1. Unless otherwise indicated, the analyses shown were performed
at 20C and measured from hatching.Cell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc. 1033
Table 1. skn-1 Contributes to the Life-Span Extension Resulting from Reduced IIS
Strain
Mean Life
Span ± SEM
20C (days)
Median
Life Span
75th
Percentile
20C (days)
25th
Percentile
20C (days)
p Value
against
Control n No. of Exp.
N2 20.44 ± 0.3 21 23 19 — 90/90 1
daf-2(e1368) 29.42 ± 0.3 31 31 29 <.0001a 91/91 1
daf-2(e1370) 39.39 ± 0.4 39 43 37 <.0001a 88/88 1
daf-16(mgDf47) 16.80 ± 0.3 17 19 15 <.0001a 50/50 1
daf-16(mgDf47); daf-2(e1370) 20.01 ± 0.1 21 21 19 <.0001b 77/80 1
skn-1(zu67) 15.60 ± 0.3 17 17 15 <.0001a 73/73 1
skn-1(zu129) 17.67 ± 0.2 17 19 17 <.0001a 90/90 1
skn-1(zu135) 17.70 ± 0.3 17 19 17 <.0001a 57/57 1
daf-2(e1368); skn-1(zu67) 22.63 ± 0.5 23 25 21 <.0001c 60/60 1
daf-2(e1368); skn-1(zu129) 22.25 ± 1.1 19 29 15 <.0001c 58/60 1
daf-2 (e1368); skn-1(zu135) 19.83 ± 0.6 19 23 17 <.0001c 58/59 1
daf-2(e1370); skn-1(zu67) 38.60 ± 1.0 41 43 35 .0740b 60/60 1
daf-2(e1370); skn-1(zu129) 27.64 ± 0.7 27 31 23 <.0001b 62/62 1
daf-2(e1370); skn-1(zu135) 33.16 ± 0.6 39 43 33 .6016b 25/25 1
rrf-3(pk1426); control(RNAi) 19.53 ± 0.5 19 24 17 — 57/60 1
rrf-3(pk1426); skn-1(RNAi) 20.43 ± 0.6 21 24 15 .1531g 60/60 1
rrf-3(pk1426); skn-1a/c(RNAi) 20.27 ± 0.6 21 24 15 .2313g 59/60 1
rrf-3(pk1426); daf-2(e1368) control(RNAi) 38.62 ± 1.3 40 44 34 <.0001g 52/55 1
rrf-3(pk1426); daf-2(e1368) skn-1(RNAi) 25.83 ± 1.3 21 36 17 <.0001d 56/56 1
rrf-3(pk1426); daf-2(e1368) skn-1a/c (RNAi) 26.32 ± 1.3 24 36 19 <.0001d 57/58 1
N2 [rol-6]; control(RNAi) 20.1 ± 0.3 20 22 18 — 84/84 1
skn-1(zu67); control(RNAi) 14.6 ± 0.4 14 16 12 <.0001e 87/90 1
N2 [rol-6]; cyc-1(RNAi) 42.1 ± 0.9 42 45 40 <.0001e 32/34 1
skn-1(zu67); cyc-1(RNAi) 41.9 ± 1.2 45 47 38 .5594f 38/38 1
N2 [rol-6]; cco-1(RNAi) 31.52 ± 0.5 32 34 30 <.0001e 67/69 1
skn-1(zu67); cco-1(RNAi) 35.13 ± 0.5 36 38 34 <.0001f 46/46 1
Strain
Mean Adult
Life Span ± SEM
25C (days)
Median
Life Span
75th
Percentile
25C (days)
25th
Percentile
25C (days)
p Value
against
Control n No. of Exp.
rrf-3(pk1426); control(RNAi) 12.90 ± 0.4 13 15 11 — 99/100 2
daf-16(mgDf47) 11.04 ± 0.2 11 13 9 <.0001g 138/138 3
rrf-3(pk1426); akt1;akt-2(RNAi) 22.50 ± 0.7 22 28 17 <.0001g 120/138 2
daf-16(mgdf47); rrf-3(pk1426); akt1;akt-2(RNAi) 11.03 ± 0.3 11 13 10 <.0001h 123/123 3
rrf-3(pk1426); skn-1(zu67); control(RNAi) 7.20 ± 0.2 7 8 6 <.0001g 106/106 2
rrf-3(pk1426); skn-1(zu129); control(RNAi) 9.30 ± 0.4 8 12 7 <.0001g 100/100 2
rrf-3(pk1426); skn-1(zu135); control(RNAi) 12.00 ± 0.3 12 15 9 0.1012g 150/150 3
rrf-3(pk1426); skn-1(zu67); akt-1;akt-2(RNAi) 11.60 ± 0.6 11 17 6 <.0001h 104/104 2
rrf-3(pk1426); skn-1(zu129); akt-1;akt-2(RNAi) 20.40 ± 1.0 21 28 12 0.9400h 101/104 2
rrf-3(pk1426); skn-1(zu135); akt-1;akt-2(RNAi) 17.69 ± 0.6 17 22 13 <.0001h 110/110 3
N2; control(RNAi) 13.8 ± 0.3 14 16 12 — 110/114 2
N2; sgk-1(RNAi) 22.6 ± 0.4 23 25 21 <.0001e 110/395 2
skn-1(zu67); sgk-1(RNAi) 8.2 ± 0.2 8 10 7 <.0001i 128/128 2
skn-1(zu129); sgk-1(RNAi) 9.1 ± 0.2 8 11 7 <.0001i 185/186 2
Corresponds to the data in Figures 4C–4H. SEM: standard error of the mean. 75th and 25th percentiles refer to the day at which 75% or 25% of the
population is dead. n represents total number of animals dying of old age versus those in total experiment (combined between trials where appropri-
ate). In the case of sgk-1(RNAi) the majority of exclusions are due to Egl/bag of worms phenotypes. p values were calculated as follows: aN2, bdaf-
2(e1370), cdaf-2(e1368), drrf-3(pk1426); daf-2(e1368) control(RNAi), eN2 control(RNAi), fN2 with corresponding RNAi, grrf-3(pk1426) control(RNAi),
hrrf-3(pk1426) akt-1;akt-2(RNAi), isgk-1(RNAi). Individual experiments, an additional analysis of daf-2(e1368) and daf-2(e1370), and other supporting
data are in Table S5.1034 Cell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc.
Figure 5. Transgenic Expression of SKN-1 Extends Life Span
(A) Life-span extension in otherwise WT animals carrying the SKN-1B/C S393A::GFP transgene, which expresses constitutively nuclear SKN-1C in the intestine
(see text). These independent extrachromosomal arrays were created by injecting 2.5 ng/ml transgene DNA.
(B) Life-span extension in skn-1(zu67) animals carrying skn-1 transgenes. The Ex001[SKN-1B/C::GFP], Ex008[SKN-1B/C S393A::GFP], and Ex020[SKN-1B/C
S393A::GFP] extrachromosomal arrays were originally created in WT animals by injection of 2.5, 2.5, and 10 ng/ml transgene DNA, respectively, and then
bred into skn-1(zu67). The presence of the transgene did not dramatically affect the developmental timing, brood size, or age-specific fecundity of either the
WT or skn-1 mutants (Figure S14). The life spans of WT animals carrying Ex001[SKN-1B/C::GFP] is shown for comparison.
(C) SKN-1C contributes to the life span of skn-1(zu67) Ex001[SKN-1B/C::GFP] animals. Life span is reduced comparably by skn-1 and skn-1a/c RNAi (Figure 1B).
(D) Presence of Ex008[SKN-1B/C S393A::GFP] increases the life span of daf-16(mgDf47) mutants.
(E) Transgene arrays that express constitutively nuclear SKN-1 (Ex008 or Ex020) increase skn-1(zu67) life span beyond WT when daf-16 is depleted by RNAi. Life-
span analyses were scored from hatching and performed at 20C unless otherwise stated and are summarized in Table 2. The experiments in (A) and (B) were
carried out on OP50, and the others on HT115. (C) and (D) are representative experiments, but otherwise data were combined from at least two experiments,
within which all sample sets were analyzed in parallel.
(F) Crosstalk among C. elegans transcriptional regulators that increase longevity when expressed transgenically. DAF-16 physically interacts with SIR-2.1
through 14-3-3 proteins and is required for SIR-2.1 to extend life span (Berdichevsky et al., 2006; Tissenbaum and Guarente, 2001). HSF-1 and DAF-16 are pre-
dicted to bind to some of the same promoters and regulate some pro-longevity target genes together (Hsu et al., 2003). PHA-4 shares a common cooperating
cofactor with DAF-16 (SMK-1), extends life span when DAF-16 is absent, and is required for DR to extend life span (Panowski et al., 2007). SKN-1 and DAF-16 are
inhibited directly and in parallel by IIS (this work).Cell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc. 1035
Table 2. Transgenic Expression of SKN-1 Extends Life Span
Strain
Mean Life
Span ± SEM
20C (days)
75th
Percentile
20C (days)
p value
against
control n
No. of
Exp.
N2 Ex[rol-6] 19.57 ± 0.2 21 — 129/130 2
N2 Ex008[SKN-1 S393A::GFP] 2.5 ng/ml 23.62 ± 0.3 26 <.0001a 78/78 2
N2 Ex021[SKN-1 S393A::GFP] 2.5 ng/ml 21.80 ± 0.2 23 <.0001a 117/122 2
N2 Ex022[SKN-1 S393A::GFP] 2.5 ng/ml 21.10 ± 0.3 23 <.0001a 62/62 2
N2 Ex023[SKN-1 S393A::GFP] 2.5 ng/ml 20.89 ± 0.3 23 <.0001a 96/96 2
N2 Ex024[SKN-1 S393A::GFP] 2.5 ng/ml 20.66 ± 0.4 23 <.0001a 63/63 2
N2 Ex[rol-6] 19.52 ± 0.2 21 — 236/243 3
skn-1(zu67) Ex[rol-6] 15.51 ± 0.3 18 <0.0001a 96/96 2
N2 Ex001[SKN 1B/C::GFP] 2.5 ng/ml 22.14 ± 0.3 25 <.0001b,c 146/148 2
skn-1(zu67) Ex001[SKN-1B/C::GFP] 2.5 ng/ml 23.53 ± 0.6 26 <.0001b,c 48/51 2
skn-1(zu67) Ex008[SKN-1B/C S393A::GFP] 2.5 ng/ml 25.74 ± 0.5 29 <.0001b,c 67/70 2
skn-1(zu67) Ex020[SKN-1B/C S393A::GFP] 10 ng/ml 27.16 ± 0.6 29 <.0001b,c 30/40 1
N2 Ex[rol-6]; control(RNAi) 20.60 ± 0.5 23 — 50/50 1
N2 Ex[rol-6]; skn-1(RNAi) 19.91 ± 0.4 21 0.0699f 60/60 1
N2 Ex[rol-6]; skn-1a/c(RNAi) 20.37 ± 0.4 23 0.7880f 59/60 1
skn-1(zu67) Ex001[SKN-1B/C::GFP] 2.5 ng/ml; control(RNAi) 24.20 ± 0.4 27 <.0001f 62/64 1
skn-1(zu67) Ex001[SKN-1B/C::GFP] 2.5 ng/ml ; skn-1(RNAi) 21.58 ± 0.4 23 <.0001d 84/84 1
skn-1(zu67) Ex001[SKN-1B/C::GFP] 2.5 ng/ml; skn-1a/c(RNAi) 21.06 ± 0.5 25 0.0005d 69/69 1
N2 Ex[rol-6] 20.60 ± 0.5 23 — 50/50 1
daf-16(mgDf47) 15.87 ± 0.3 17 <.0001f 8/61 1
daf-16(mgDf47) Ex008[SKN-1 S393A::GFP] 2.5 ng/ml 18.88 ± 0.3 21 <.0001e 48/48 1
N2 Ex[rol-6]; control(RNAi) 20.02 ± 0.2 22 — 256/259 4
N2 Ex[rol-6]; daf-16(RNAi) 17.77 ± 0.1 19 <.0001f 266/266 4
skn-1(zu67) Ex[rol-6]; control(RNAi) 17.38 ± 0.3 20 <.0001f 145/146 3
skn-1(zu67) Ex[rol-6]; daf-16(RNAi) 16.59 ± 0.3 19 0.0240g 142/145 3
skn-1(zu67)Ex001[SKN-1b/c::GFP] 2.5 ng/ml; control(RNAi) 22.95 ± 0.5 26 <.0001g 62/62 2
skn-1(zu67) Ex001[SKN-1b/c::GFP] 2.5 ng/ml; daf-16(RNAi) 16.53 ± 0.3 18 0.1655h 59/59 2
skn-1(zu67) Ex008[SKN-1 S393A::GFP] 2.5 ng/ml; control(RNAi) 24.28 ± 0.6 28 <.0001g 64/76 3
skn-1(zu67) Ex008[SKN-1 S393A::GFP] 2.5 ng/ml; daf-16(RNAi) 21.12 ± 0.4 23 <.0001h,i 76/87 3
skn-1(zu67) Ex020[SKN-1 S393A::GFP] 10 ng/ml; control(RNAi) 25.10 ± 0.6 28 <.0001g 121/132 3
skn-1(zu67) Ex020[SKN-1 S393A::GFP] 10 ng/ml; daf-16(RNAi) 21.39 ± 0.4 24 <.0001h,i 124/140 3
Corresponds to the data in Figures 5A–5E. p values were calculated as follows: aN2 Ex[rol-6], bskn-1(zu67)[rol-6], csignificantly enhanced compared to
N2 [rol-6] (p = < 0.0001 in each case), dskn-1(zu67) Ex001 control(RNAi), edaf-16(mgDf47) control(RNAi), fN2 Ex[rol-6] control(RNAi), gskn-1(zu67)[rol-6]
control(RNAi), hskn-1(zu67)[rol-6] daf-16(RNAi), icompared to N2 Ex[rol-6] control(RNAi) (p = 0.0021 for skn-1(zu67) Ex008 and p = 0.0001 for
skn-1(zu67) Ex020). Individual experiments and additional analysis of daf-16 Ex008[SKN-1S393A::GFP] are in Table S6. Tabulated as in Table 1.simultaneous overexpression of both transcription factors is nec-
essary, although modifications of these proteins or other signals
associated with decreased IIS might also be required. Our obser-
vation thatdaf-16RNAi suppressed life-span extension by the WT
SKN-1B/C::GFP transgene (Figure S13) suggests that DAF-16
may influence processes that regulate SKN-1. This could involve
DAF-16 regulating genes that affect SKN-1, but a simpler model is
that SKN-1 and DAF-16 compete for binding to negative regula-
tors that include AKT-1, -2, and SGK-1 (Figure 1A). Thus, decreas-
ing DAF-16 levels would increase the ratio of negative regulators
available to sequester SKN-1 in the cytoplasm.
Our results add SKN-1 to the small group of C. elegans tran-
scription regulators that extend longevity when expressed trans-1036 Cell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc.genically (Figure 5F). SIR-2.1, PHA-4, DAF-16, and SKN-1 or
their orthologs have all been shown to influence aspects of
metabolism and thereby presumably may affect the rates of
damage that lead to aging (Accili and Arden, 2004; Bishop and
Guarente, 2007; Kenyon, 2005; Panowski et al., 2007; van der
Horst and Burgering, 2007). Importantly, SKN-1, HSF-1, and
each of these other proteins have also been implicated in resis-
tance to free radical or other stresses (Figure 5F; see text),
supporting the idea that stress defenses and detoxification are
fundamentally important for longevity. A remarkable web of func-
tional interactions among these factors has been uncovered,
including our demonstration here that DAF-16 and SKN-1 are
regulated in parallel by IIS (Figure 5F). These interactions could
be important for coordinating how these proteins respond in
different tissues to various scenarios of nutrient availability and
stress. As these regulators are also evolutionarily conserved, it
seems likely that a deeper understanding of interactions among
them will be broadly relevant to elucidating how these proteins
influence metabolism, stress resistance, and possibly longevity
across species.
EXPERIMENTAL PROCEDURES
All Supplemental Data and experimental procedures, including details of clon-
ing, strains, RNAi, GFP scoring system, and assays for life span, movement,
and reproduction are available online.
In Vitro Kinase Assay
Kinases were isolated from sonicated worm lysates of N2 Ex[AKT-1::GFP], N2
Ex[AKT-2::GFP], and N2 Ex[AKT-1::GFP] (Hertweck et al., 2004), using a GFP
antibody bound to protein A/G agarose beads. These purified kinases were
used to phosphorylate 6 mg of bacterially expressed GST-SKN-1 fusion
proteins in the presence of 6 mCi [gP32]ATP. After phosphorylation, samples
were washed in 50 mM Tris/HCl (pH 8.0), 100 mM NaCl, 10% glycerol, and
1% Triton X-100 and analyzed by SDS-PAGE and autoradiography.
RNAi
Feeding RNAi was carried out as previously described, with empty pL4440 as
the control (Supplemental Experimental Procedures). To avoid maternal lethal-
ity in experiments using skn-1 or skn-1a/c RNAi, animals were hatched on
HT115 bacteria expressing control RNAi and were transferred to skn-1 RNAi
at the L1 stage or on the first day of adulthood. For life-span experiments
that required feeding of other RNAi, animals were exposed to bacteria
expressing the appropriate construct continually starting from hatching.
Life-Span Analysis
Prior to experiments, all animals were maintained at the permissive tempera-
ture and grown for at least two generations in the presence of food to assure
health. Life-span assays were performed essentially as described (Hsin and
Kenyon, 1999; Supplemental Experimental Procedures). Survival plots,
p values (Log-Rank), and proportional hazards were determined using JMP
software, version 5.1.
Oxidative Stress Resistance Assay
To assess stress resistance, young adults were transferred to plates that
contained 7.5 mM t-butyl hydrogen peroxide (Sigma) or 150 mM paraquat
(Sigma) in nematode growth media. These plates had been seeded with
OP50 or HT115 expressing the appropriate dsRNAs. Animals were incubated
on these plates at 20C and periodically scored for survival.
RNA Isolation and Quantitative PCR
Animals were picked to clean plates to minimize contamination, then total RNA
was extracted from approximately 200 animals suspended in 50 ml M9. RNA
was extracted using Trizol (Sigma) and cDNA was synthesized using the Invi-
trogen Superscript Reverse Transcriptase Kit. SYBR Green Real Time PCR
was carried out using the ABI 7700 and normalized to act-1. Primer sequences
are available on request.
SUPPLEMENTAL DATA
Supplemental Data include Experimental Procedures, six tables, and fourteen
figures and can be found with this article online at http://www.cell.com/cgi/
content/full/132/6/1025/DC1/.
ACKNOWLEDGMENTS
We thank Siu Sylvia Lee, Gary Ruvkun, and Laura Mitic for generously provid-
ing advice and strains; Stacey Robida, Anne Oelmann, Jeeyong Lee, andMichael Lucke for invaluable technical support; and members of the Blackwell
lab, Javier Apfeld, and Rohit Kulkarni for critically reading this manuscript.
Work was supported by funding from the NIH (grant number 2 R01
GM062891) and Iacocca Foundation (T.K.B.), the Fonds der Chemischen In-
dustrie, BMBF FRISYS, Qualitaetsoffensive BW, and Deutsche Forschungsge-
meinschaft CRC746 (R.B.), and EC 6th Framework Network of Excellence LIFE-
SPAN (LSHG-CT-2007-036894) (R.B. and M.H.), as well as an NRSA (number 5
F32 GM070088-02) (R.P.O.), an NIH training grant (number T32 DK07260)
(J.B.), and KRF (2006-353-C00035) and MOST/KOSEF(R112000078010010)
(J.H.A.).
Received: June 29, 2007
Revised: December 18, 2007
Accepted: January 18, 2008
Published: March 20, 2008
REFERENCES
Accili, D., and Arden, K.C. (2004). FoxOs at the crossroads of cellular
metabolism, differentiation, and transformation. Cell 117, 421–426.
An, J.H., and Blackwell, T.K. (2003). SKN-1 links C. elegans mesendodermal
specification to a conserved oxidative stress response. Genes Dev. 17,
1882–1893.
An, J.H., Vranas, K., Lucke, M., Inoue, H., Hisamoto, N., Matsumoto, K., and
Blackwell, T.K. (2005). Regulation of the Caenorhabditis elegans oxidative
stress defense protein SKN-1 by glycogen synthase kinase-3. Proc. Natl.
Acad. Sci. USA 102, 16275–16280.
Antebi, A. (2007). Genetics of aging in Caenorhabditis elegans. PLoS Genet. 3,
1565–1571. 10.1371/journal.pgen.0030129.
Arantes-Oliveira, N., Apfeld, J., Dillin, A., and Kenyon, C. (2002). Regulation
of life-span by germ-line stem cells in Caenorhabditis elegans. Science 295,
502–505.
Berdichevsky, A., Viswanathan, M., Horvitz, H.R., and Guarente, L. (2006). C.
elegans SIR-2.1 interacts with 14–3-3 proteins to activate DAF-16 and extend
life span. Cell 125, 1165–1177.
Bishop, N.A., and Guarente, L. (2007). Two neurons mediate diet-restriction-
induced longevity in C. elegans. Nature 447, 545–549.
Bowerman, B., Eaton, B.A., and Priess, J.R. (1992). skn-1, a maternally
expressed gene required to specify the fate of ventral blastomeres in the early
C. elegans embryo. Cell 68, 1061–1075.
Brunet, A., Park, J., Tran, H., Hu, L.S., Hemmings, B.A., and Greenberg, M.E.
(2001). Protein kinase SGK mediates survival signals by phosphorylating the
forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 21, 952–965.
Cahill,C.M., Tzivion,G.,Nasrin,N.,Ogg,S.,Dore, J.,Ruvkun,G.,andAlexander-
Bridges, M. (2001). Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA
binding and function via 14–3-3-dependent and 14–3-3-independent pathways.
J. Biol. Chem. 276, 13402–13410.
Dillin, A., Hsu, A.L., Arantes-Oliveira, N., Lehrer-Graiwer, J., Hsin, H., Fraser,
A.G., Kamath, R.S., Ahringer, J., and Kenyon, C. (2002). Rates of behavior
and aging specified by mitochondrial function during development. Science
298, 2398–2401.
Finkel, T., and Holbrook, N.J. (2000). Oxidants, oxidative stress and the
biology of ageing. Nature 408, 239–247.
Friedman, D.B., and Johnson, T.E. (1988). A mutation in the age-1 gene in
Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility.
Genetics 118, 75–86.
Gems, D., Sutton, A.J., Sundermeyer, M.L., Albert, P.S., King, K.V., Edgley,
M.L., Larsen, P.L., and Riddle, D.L. (1998). Two pleiotropic classes of daf-2
mutation affect larval arrest, adult behavior, reproduction and longevity in
Caenorhabditis elegans. Genetics 150, 129–155.
Goldstein, B.J., Mahadev, K., and Wu, X. (2005). Redox paradox: insulin action
is facilitated by insulin-stimulated reactive oxygen species with multiple poten-
tial signaling targets. Diabetes 54, 311–321.Cell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc. 1037
Gottlieb, S., and Ruvkun, G. (1994). daf-2, daf-16 and daf-23: genetically inter-
acting genes controlling Dauer formation in Caenorhabditis elegans. Genetics
137, 107–120.
Greer, E.L., Dowlatshahi, D., Banko, M.R., Villen, J., Hoang, K., Blanchard, D.,
Gygi, S.P., and Brunet, A. (2007). An AMPK-FOXO pathway mediates longevity
induced by a novel method of dietary restriction in C. elegans. Curr. Biol. 17,
1646–1656.
Hayes, J.D., and McMahon, M. (2001). Molecular basis for the contribution of
the antioxidant responsive element to cancer chemoprevention. Cancer Lett.
174, 103–113.
Henderson, S.T., and Johnson, T.E. (2001). daf-16 integrates developmental
and environmental inputs to mediate aging in the nematode Caenorhabditis
elegans. Curr. Biol. 11, 1975–1980.
Hertweck, M., Gobel, C., and Baumeister, R. (2004). C. elegans SGK-1 is the
critical component in the Akt/PKB kinase complex to control stress response
and life span. Dev. Cell 6, 577–588.
Houthoofd, K., Braeckman, B.P., Lenaerts, I., Brys, K., De Vreese, A.,
Van Eygen, S., and Vanfleteren, J.R. (2002). Axenic growth up-regulates
mass-specific metabolic rate, stress resistance, and extends life span in
Caenorhabditis elegans. Exp. Gerontol. 37, 1371–1378.
Houthoofd, K., Braeckman, B.P., Johnson, T.E., and Vanfleteren, J.R. (2003).
Life extension via dietary restriction is independent of the Ins/IGF-1 signalling
pathway in Caenorhabditis elegans. Exp. Gerontol. 38, 947–954.
Hsin, H., and Kenyon, C. (1999). Signals from the reproductive system regulate
the lifespan of C. elegans. Nature 399, 362–366.
Hsu, A.L., Murphy, C.T., and Kenyon, C. (2003). Regulation of aging and age-
related disease by DAF-16 and heat-shock factor. Science 300, 1142–1145.
Inoue, H., Hisamoto, N., An, J.H., Oliveira, R.P., Nishida, E., Blackwell, T.K.,
and Matsumoto, K. (2005). The C. elegans p38 MAPK pathway regulates
nuclear localization of the transcription factor SKN-1 in oxidative stress
response. Genes Dev. 19, 2278–2283.
Kell, A., Ventura, N., Kahn, N., and Johnson, T.E. (2007). Activation of SKN-1
by novel kinases in Caenorhabditis elegans. Free Radic. Biol. Med. 43,
1560–1566.
Kenyon, C. (2005). The plasticity of aging: insights from long-lived mutants.
Cell 120, 449–460.
Kenyon, C., Chang, J., Gensch, E., Rudner, A., and Tabtiang, R. (1993). A C.
elegans mutant that lives twice as long as wild type. Nature 366, 461–464.1038 Cell 132, 1025–1038, March 21, 2008 ª2008 Elsevier Inc.Kimura, K.D., Tissenbaum, H.A., Liu, Y., and Ruvkun, G. (1997). daf-2, an insu-
lin receptor-like gene that regulates longevity and diapause in Caenorhabditis
elegans. Science 277, 942–946.
Lakowski, B., and Hekimi, S. (1996). Determination of life-span in Caenorhab-
ditis elegans by four clock genes. Science 272, 1010–1013.
Larsen, P.L. (1993). Aging and resistance to oxidative damage in Caenorhab-
ditis elegans. Proc. Natl. Acad. Sci. USA 90, 8905–8909.
Lee, S.S., Lee, R.Y., Fraser, A.G., Kamath, R.S., Ahringer, J., and Ruvkun, G.
(2003). A systematic RNAi screen identifies a critical role for mitochondria in C.
elegans longevity. Nat. Genet. 33, 40–48.
Lin, K., Hsin, H., Libina, N., and Kenyon, C. (2001). Regulation of the Caeno-
rhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline
signaling. Nat. Genet. 28, 139–145.
Lithgow, G.J., and Walker, G.A. (2002). Stress resistance as a determinate of
C. elegans lifespan. Mech. Ageing Dev. 123, 765–771.
McMahon, M., Itoh, K., Yamamoto, M., Chanas, S.A., Henderson, C.J.,
McLellan, L.I., Wolf, C.R., Cavin, C., and Hayes, J.D. (2001). The Cap’n’Collar
basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2)
controls both constitutive and inducible expression of intestinal detoxification
and glutathione biosynthetic enzymes. Cancer Res. 61, 3299–3307.
Ogg, S., Paradis, S., Gottlieb, S., Patterson, G.I., Lee, L., Tissenbaum, H.A.,
and Ruvkun, G. (1997). The Fork head transcription factor DAF-16 transduces
insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994–999.
Panowski, S.H., Wolff, S., Aguilaniu, H., Durieux, J., and Dillin, A. (2007). PHA-
4/Foxa mediates diet-restriction-induced longevity of C. elegans. Nature 447,
550–555.
Rea, S.L., Ventura, N., and Johnson, T.E. (2007). Relationship between
mitochondrial electron transport chain dysfunction, development, and life
extension in Caenorhabditis elegans. PLoS Biol. 5, e259. 10.1371/journal.
pbio.0050259.
Simmer, F., Tijsterman, M., Parrish, S., Koushika, S.P., Nonet, M.L., Fire, A.,
Ahringer, J., and Plasterk, R.H. (2002). Loss of the putative RNA-directed
RNA polymerase RRF-3 makes C. elegans hypersensitive to RNAi. Curr.
Biol. 12, 1317–1319.
Tissenbaum, H.A., and Guarente, L. (2001). Increased dosage of a sir-2 gene
extends lifespan in Caenorhabditis elegans. Nature 410, 227–230.
Tonks, N.K. (2005). Redox redux: revisiting PTPs and the control of cell signal-
ing. Cell 121, 667–670.
van der Horst, A., and Burgering, B.M. (2007). Stressing the role of FoxO
proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol. 8, 440–450.
